FROM Herbert Kleber
A Psychedelic Revival in Modern Medicine The over-use and abuse of LSD, magic mushrooms and other hallucinogens in the counter-cultural sixties led to a federal ban signed by Richard Nixon in 1970. Nobody says it's time to "tune in, turn on and drop out" again, but researchers around the country report that psychedelics have real medical benefits after all. They've eased the anxiety of terminal cancer patients and helped suicidal veterans with PTSD want to live again, as highlighted in a recent article by Michael Pollan in the New Yorker magazine. But the risk of adverse side effects has medical authorities preaching caution about continued experimentation.
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.
White House budget proposal slashes and burns President Trump's first budget request is considered dead on arrival in Congress — a familiar development in Capitol Hill. We hear what it reveals about the priorities of the new administration. What's likely to die… and what might survive?
Trump plays scolder-in-chief with NATO allies At the opening of NATO’s dramatic new headquarters in Brussels today, President Trump acknowledged that Article 5 — promising that “an attack on one nation is an attack on all” -- has only been invoked one time: in the aftermath of September 11. But the President failed to provide what 27 other Alliance members have been waiting for: a re-commitment by America’s new leader to Article 5. Instead, they got a scolding.
Is the threat from Russia missing from the Russia meddling probe? There's much being made about the Trump administration's possible ties with Russia. But the bottom line is Russia's effort to influence American democracy. Do the President and his aides care enough to take action before voters go back to the polls?